Vertex Pharma scientist talks about the long road to developing non
Release time：2024-04-30 19:26:52 Source：Culture Compass news portal
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
- Previous：Daniel Day
- Next：Russell Brand announces plan to be baptised as it's 'an opportunity to leave the past behind'
Related articles
- Morel hits tiebreaking HR off Díaz in 9th and Cubs top Mets 3
- Suárez runs shutout streak to 25 innings as Phillies blank Reds 7
- 19th Western Pacific Naval Symposium set to take place in E China
- Chinese company issues carbon
- GOP leaders still can't overcome the Kansas governor's veto to enact big tax cuts
- Tensions between Beijing, Washington biggest worry for US companies in China
- Massive flooding hits China's Guangdong
- MLB players' union asks court to confirm arbitration decision against Bad Bunny firm
- ‘Welcome to Wrexham’ returns for a ‘nail
- Is Hayley Atwell pregnant? Tom Cruise's ex, 42, cradles her tummy during romantic Venetian mini
- Real Madrid coach Carlo Ancelotti apologizes for forgetting German on his Bayern Munich return
- Facing pressure from rights groups, World Bank suspends funding for Tanzania tourism project
- 'Openly Jewish' charity chief says Met boss Mark Rowley has 'failed abjectly' to stand up for Jews
- Travis d'Arnaud homers again and Bryce Elder shuts down Marlins in Braves' 3
- Faye Dunaway orders crew member off set for being in her eye line in newly
- Ecuador violence: Ecuadorians approve referendum measures to toughen fight against gangs
- Streamlined logistics allow landlocked regions to expand global reach
- REVEALED: Larry Ellison son's David, 41, and his bid to buy media giant Paramount
- 1 dead, 2 injured in shooting on Navajo Nation in northern Arizona
- Israeli military intelligence chief resigns over failure to prevent Hamas attack
Random recommendation
- Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,Culture Compass news portal sitemap